Landscapes / Companies
NS Pharma, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
6
in active trials · 7 in all
Trials
8 active
14 since 2021
Drugs6
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Sep 2032Phase 4 trial completes | |||
| Next date | Sep 2032 · Phase 4 trial completes | ||||
| Also tested for | Duchenne Muscular Dystrophy | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2026Phase 2 trial completes | |||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome | ||||
| Open drug page | |||||
— |
Nippon Shinyaku |
Phase 2 | 26 Feb 2027Phase 2 trial completes | ||
| Next date | 26 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Duchenne Muscular Dystrophy, Exon 44 and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Mar 2028Phase 1/2 trial completes | |||
| Next date | Mar 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Duchenne Muscular Dystrophy | ||||
| Open drug page | |||||
— |
Phase 2 | 1 Aug 2028Phase 2 trial completes | |||
| Next date | 1 Aug 2028 · Phase 2 trial completes | ||||
| Also tested for | Pulmonary Arterial Hypertension, Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | ||||
| Open drug page | |||||
Brogidirsennot checked |
— |
Phase 2 | 3 Sep 2029Phase 2 trial completes | ||
| Next date | 3 Sep 2029 · Phase 2 trial completes | ||||
| Also tested for | Duchenne Muscular Dystrophy, Exon 44 and 1 more | ||||
| Open drug page | |||||
About
- No active trial
- NS-018
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021